181 related articles for article (PubMed ID: 31170660)
1. Chemical screen for epigenetic barriers to single allele activation of Oct4.
Headley KM; Kedziora KM; Alejo A; Lai EZ; Purvis JE; Hathaway NA
Stem Cell Res; 2019 Jul; 38():101470. PubMed ID: 31170660
[TBL] [Abstract][Full Text] [Related]
2. Targeted Gene Repression Using Novel Bifunctional Molecules to Harness Endogenous Histone Deacetylation Activity.
Butler KV; Chiarella AM; Jin J; Hathaway NA
ACS Synth Biol; 2018 Jan; 7(1):38-45. PubMed ID: 29073761
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional reprogramming and chromatin remodeling accompanies Oct4 and Nanog silencing in mouse trophoblast lineage.
Carey TS; Choi I; Wilson CA; Floer M; Knott JG
Stem Cells Dev; 2014 Feb; 23(3):219-29. PubMed ID: 24059348
[TBL] [Abstract][Full Text] [Related]
4. Tethering of Lsh at the Oct4 locus promotes gene repression associated with epigenetic changes.
Ren J; Hathaway NA; Crabtree GR; Muegge K
Epigenetics; 2018; 13(2):173-181. PubMed ID: 28621576
[TBL] [Abstract][Full Text] [Related]
5. Going up the hill: chromatin-based barriers to epigenetic reprogramming.
Arabacı DH; Terzioğlu G; Bayırbaşı B; Önder TT
FEBS J; 2021 Aug; 288(16):4798-4811. PubMed ID: 33190371
[TBL] [Abstract][Full Text] [Related]
6. Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers.
Bultmann S; Morbitzer R; Schmidt CS; Thanisch K; Spada F; Elsaesser J; Lahaye T; Leonhardt H
Nucleic Acids Res; 2012 Jul; 40(12):5368-77. PubMed ID: 22387464
[TBL] [Abstract][Full Text] [Related]
7. Identification of Oct4-activating compounds that enhance reprogramming efficiency.
Li W; Tian E; Chen ZX; Sun G; Ye P; Yang S; Lu D; Xie J; Ho TV; Tsark WM; Wang C; Horne DA; Riggs AD; Yip ML; Shi Y
Proc Natl Acad Sci U S A; 2012 Dec; 109(51):20853-8. PubMed ID: 23213213
[TBL] [Abstract][Full Text] [Related]
8. Dynamic epigenetic regulation of the Oct4 and Nanog regulatory regions during neural differentiation in rhesus nuclear transfer embryonic stem cells.
Wang K; Chen Y; Chang EA; Knott JG; Cibelli JB
Cloning Stem Cells; 2009 Dec; 11(4):483-96. PubMed ID: 20025521
[TBL] [Abstract][Full Text] [Related]
9. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
10. Global transcriptional analysis of nuclear reprogramming in the transition from MEFs to iPSCs.
Dong F; Song Z; Zhang J; Lu Y; Song C; Jiang B; Zhang B; Cong P; Sun H; Shi F; Liu H
Genes Cells; 2013 Jan; 18(1):42-55. PubMed ID: 23231677
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
12. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2.
Doege CA; Inoue K; Yamashita T; Rhee DB; Travis S; Fujita R; Guarnieri P; Bhagat G; Vanti WB; Shih A; Levine RL; Nik S; Chen EI; Abeliovich A
Nature; 2012 Aug; 488(7413):652-5. PubMed ID: 22902501
[TBL] [Abstract][Full Text] [Related]
13. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.
Li Y; Zhang Q; Yin X; Yang W; Du Y; Hou P; Ge J; Liu C; Zhang W; Zhang X; Wu Y; Li H; Liu K; Wu C; Song Z; Zhao Y; Shi Y; Deng H
Cell Res; 2011 Jan; 21(1):196-204. PubMed ID: 20956998
[TBL] [Abstract][Full Text] [Related]
14. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
[TBL] [Abstract][Full Text] [Related]
16. Radical acceleration of nuclear reprogramming by chromatin remodeling with the transactivation domain of MyoD.
Hirai H; Tani T; Katoku-Kikyo N; Kellner S; Karian P; Firpo M; Kikyo N
Stem Cells; 2011 Sep; 29(9):1349-61. PubMed ID: 21732495
[TBL] [Abstract][Full Text] [Related]
17. Histone demethylase complexes KDM3A and KDM3B cooperate with OCT4/SOX2 to define a pluripotency gene regulatory network.
Zhu Z; Wu X; Li Q; Zhang J; Yu S; Shen Q; Zhou Z; Pan Q; Yue W; Qin D; Zhang Y; Zhao W; Zhang R; Peng S; Li N; Zhang S; Lei A; Miao YL; Liu Z; Chen X; Wang H; Liao M; Hua J
FASEB J; 2021 Jun; 35(6):e21664. PubMed ID: 34042215
[TBL] [Abstract][Full Text] [Related]
18. Analysis of endogenous Oct4 activation during induced pluripotent stem cell reprogramming using an inducible Oct4 lineage label.
Greder LV; Gupta S; Li S; Abedin MJ; Sajini A; Segal Y; Slack JM; Dutton JR
Stem Cells; 2012 Nov; 30(11):2596-601. PubMed ID: 22948941
[TBL] [Abstract][Full Text] [Related]
19. Intrachromosomal looping is required for activation of endogenous pluripotency genes during reprogramming.
Zhang H; Jiao W; Sun L; Fan J; Chen M; Wang H; Xu X; Shen A; Li T; Niu B; Ge S; Li W; Cui J; Wang G; Sun J; Fan X; Hu X; Mrsny RJ; Hoffman AR; Hu JF
Cell Stem Cell; 2013 Jul; 13(1):30-5. PubMed ID: 23747202
[TBL] [Abstract][Full Text] [Related]
20. Disruption of OCT4 Ubiquitination Increases OCT4 Protein Stability and ASH2L-B-Mediated H3K4 Methylation Promoting Pluripotency Acquisition.
Li S; Xiao F; Zhang J; Sun X; Wang H; Zeng Y; Hu J; Tang F; Gu J; Zhao Y; Jin Y; Liao B
Stem Cell Reports; 2018 Oct; 11(4):973-987. PubMed ID: 30269953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
